Vicor Operating Cash Flow decreased by 125.1% to -$3.94M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 119.6%, from $20.13M to -$3.94M. Over 4 years (FY 2021 to FY 2025), Operating Cash Flow shows an upward trend with a 26.5% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $12.34M | $10.11M | $14.22M | $4.59M | $10.82M | $6.60M | $929.00K | $10.11M | $19.04M | $23.84M | $21.53M | $2.58M | $15.57M | $22.58M | $10.12M | $20.13M | $65.23M | $38.49M | $15.71M | -$3.94M |
| QoQ Change | — | -18.1% | +40.6% | -67.7% | +136.1% | -39.0% | -85.9% | +988.6% | +88.3% | +25.2% | -9.7% | -88.0% | +502.9% | +45.0% | -55.2% | +99.0% | +224.1% | -41.0% | -59.2% | -125.1% |
| YoY Change | — | — | — | — | -12.3% | -34.7% | -93.5% | +120.6% | +75.9% | +261.1% | >999% | -74.5% | -18.2% | -5.3% | -53.0% | +679.6% | +319.0% | +70.5% | +55.3% | -119.6% |